Yin J, Li J, Wang H
Discov Oncol. 2025; 16(1):308.
PMID: 40072658
PMC: 11904034.
DOI: 10.1007/s12672-025-02053-w.
Bright R
Hum Vaccin Immunother. 2023; 19(3):2273699.
PMID: 37904517
PMC: 10760363.
DOI: 10.1080/21645515.2023.2273699.
Druml T, Brem G, Velie B, Lindgren G, Horna M, Ricard A
BMC Vet Res. 2021; 17(1):336.
PMID: 34696794
PMC: 8543801.
DOI: 10.1186/s12917-021-03046-x.
Melixetian M, Bossi D, Mihailovich M, Punzi S, Barozzi I, Marocchi F
EMBO Rep. 2021; 22(3):e50852.
PMID: 33586907
PMC: 7926219.
DOI: 10.15252/embr.202050852.
Vincent K, Postovit L
Oncotarget. 2017; 8(6):10498-10509.
PMID: 28060736
PMC: 5354675.
DOI: 10.18632/oncotarget.14443.
Functional Characterization of MC1R-TUBB3 Intergenic Splice Variants of the Human Melanocortin 1 Receptor.
Herraiz C, Olivares C, Castejon-Grinan M, Abrisqueta M, Jimenez-Cervantes C, Garcia-Borron J
PLoS One. 2015; 10(12):e0144757.
PMID: 26657157
PMC: 4676704.
DOI: 10.1371/journal.pone.0144757.
Overexpressed oncogenic tumor-self antigens.
Bright R, Bright J, Byrne J
Hum Vaccin Immunother. 2014; 10(11):3297-305.
PMID: 25483660
PMC: 4514139.
DOI: 10.4161/hv.29475.
Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.
Yilmaz-Ozcan S, Sade A, Kucukkaraduman B, Kaygusuz Y, Senses K, Banerjee S
PLoS One. 2014; 9(9):e107905.
PMID: 25229454
PMC: 4168264.
DOI: 10.1371/journal.pone.0107905.
Identification of genomic locus responsible for experimentally induced testicular teratoma 1 (ett1) on mouse Chr 18.
Miyazaki T, Ikeda Y, Kubo I, Suganuma S, Fujita N, Itakura M
Mamm Genome. 2014; 25(7-8):317-26.
PMID: 24997020
DOI: 10.1007/s00335-014-9529-8.
TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.
Lauden L, Siewiera J, Boukouaci W, Ramgolam K, Mourah S, Lebbe C
J Invest Dermatol. 2014; 134(6):1675-1685.
PMID: 24499734
DOI: 10.1038/jid.2014.20.
Effects of the Arg-Pro and Gly-Gly-Nle Moieties on Melanocortin-1 Receptor Binding Affinities of α-MSH Peptides.
Yang J, Liu L, Miao Y
ACS Med Chem Lett. 2013; 4(10).
PMID: 24349641
PMC: 3859464.
DOI: 10.1021/ml400309u.
Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.
Liu D, Liu X, Xing M
Cell Cycle. 2013; 13(2):208-19.
PMID: 24200969
PMC: 3906238.
DOI: 10.4161/cc.26971.
Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells.
James R, Bosch K, Kulikauskas R, Yang P, Robin N, Toroni R
J Biol Chem. 2013; 288(48):34658-70.
PMID: 24114839
PMC: 3843078.
DOI: 10.1074/jbc.M113.500314.
Melanoma biomolecules: independently identified but functionally intertwined.
Dye D, Medic S, Ziman M, Coombe D
Front Oncol. 2013; 3:252.
PMID: 24069584
PMC: 3781348.
DOI: 10.3389/fonc.2013.00252.
Molecular changes induced by the curcumin analogue D6 in human melanoma cells.
Rozzo C, Fanciulli M, Fraumene C, Corrias A, Cubeddu T, Sassu I
Mol Cancer. 2013; 12:37.
PMID: 23642048
PMC: 3651720.
DOI: 10.1186/1476-4598-12-37.
A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis.
Liu W, Peng Y, Tobin D
PeerJ. 2013; 1:e49.
PMID: 23638386
PMC: 3628745.
DOI: 10.7717/peerj.49.
Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.
Raskin L, Fullen D, Giordano T, Thomas D, Frohm M, Cha K
J Invest Dermatol. 2013; 133(11):2585-2592.
PMID: 23633021
PMC: 4267221.
DOI: 10.1038/jid.2013.197.
Forging a link between oncogenic signaling and immunosuppression in melanoma.
Khalili J, Hwu P, Lizee G
Oncoimmunology. 2013; 2(2):e22745.
PMID: 23525189
PMC: 3601157.
DOI: 10.4161/onci.22745.
A nine-gene signature predicting clinical outcome in cutaneous melanoma.
Brunner G, Reitz M, Heinecke A, Lippold A, Berking C, Suter L
J Cancer Res Clin Oncol. 2012; 139(2):249-58.
PMID: 23052696
DOI: 10.1007/s00432-012-1322-z.
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.
Meyer S, Fuchs T, Bosserhoff A, Hofstadter F, Pauer A, Roth V
PLoS One. 2012; 7(6):e38222.
PMID: 22685558
PMC: 3369875.
DOI: 10.1371/journal.pone.0038222.